Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (DEFICIENCY) (Details 3)

v3.19.1
STOCKHOLDERS' EQUITY (DEFICIENCY) (Details 3) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Stock-based compensation $ 889 $ 800
Research and Development Expense [Member]    
Stock-based compensation 30
Selling and Marketing Expense [Member]    
Stock-based compensation 16 13
General and Administrative Expense [Member]    
Stock-based compensation $ 873 $ 757